Study S000663

A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT00500370
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: TRIPLE
Status: COMPLETED
Enrollment: 163
Start: 2007-06
Primary completion: 2008-02
Lead sponsor: AstraZeneca
Conditions: Obesity
Interventions: DRUG:exenatide; DRUG:placebo
Results posted: TRUE

Registered primary outcomes

Change in Body Weight [24 weeks]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0026955	Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes. Rosenstock J, Diabetes care	2010	Randomized trial	PMID 20332357 DOI	cites ClinicalTrials.gov:NCT00500370; registry reference DERIVED:20332357